Upadacitinib

Active Ingredient: Upadacitinib
Form: Oral tablet
Brand Name: Rinvoq
Generic Name: Upanib
Generic Manufacturer: Ziska Pharmaceuticals

Indications:
Rinvoq is an oral JAK1 inhibitor developed by AbbVie and approved by the FDA and EMA. It is used to treat autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, and ulcerative colitis. Specifically, it is indicated for adults with moderate to severe active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate.

Dosage and Administration:
The recommended dose is 15 mg orally once daily. Rinvoq may be used as monotherapy or in combination with methotrexate or other non-biologic disease-modifying antirheumatic drugs (DMARDs). Complete blood counts should be assessed prior to initiation. Dose adjustment may be required if lab parameters fall below safe thresholds.

Common Side Effects:
Upper respiratory tract infections, nausea, cough, and fever.

Storage:
Store below 25°C in a cool, dry place away from light. Keep out of reach of children.

Frequently Asked Questions

Q: What is the relationship between Rinvoq and Upadacitinib?
A: Rinvoq is the brand name registered by the original manufacturer. Upadacitinib is the active ingredient.

Q: Is the Rinvoq sold by Mediva Rx the original brand-name drug?
A: No. Mediva Rx offers a high-quality generic version manufactured by one of Bangladesh’s top 10 pharmaceutical companies. It contains the same active ingredient and therapeutic effect as the original and is tested and approved by the Directorate General of Drug Administration (DGDA).

Q: Is the manufacturer of the Rinvoq generic version reliable?
A: Yes. We work with Ziska Pharmaceuticals, one of Bangladesh’s leading pharmaceutical manufacturers. They operate in-house R&D, production, and quality control labs and are internationally GMP-certified. You can purchase with confidence.

Disclaimer:
This information is for reference only. Treatment decisions should always be made in consultation with your physician and based on the official prescribing information and the latest clinical research.

Drug Instructions (Package Insert):
Download Link